Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Linsitinib | 0.01 | uM | 9 | 1250.00 | 830.55 | 2223.00 | 1962.75 | 1.1326 | 1.2111 |
| SK-BR-3 | 17-AAG | 0.1 | uM | 9 | 1250.00 | 830.55 | 785.00 | 1962.75 | 0.4000 | -0.0444 |
| SK-BR-3 | Lapatinib | 0.01 | uM | 9 | 1250.00 | 830.55 | 1608.00 | 1962.75 | 0.8193 | 0.7031 |
| SK-BR-3 | Lapatinib | 0.31623 | uM | 9 | 1250.00 | 830.55 | 904.00 | 1962.75 | 0.4606 | 0.0707 |
| SK-BR-3 | 17-AAG | 0.31623 | uM | 9 | 1250.00 | 830.55 | 694.00 | 1962.75 | 0.3536 | -0.1348 |
| SK-BR-3 | Erlotinib | 0.1 | uM | 9 | 1250.00 | 830.55 | 1837.00 | 1962.75 | 0.9359 | 0.8961 |
| SK-BR-3 | 0 | uM | 9 | 1250.00 | 830.55 | 1849.00 | 1962.75 | 0.9421 | 0.9060 | |
| SK-BR-3 | Erlotinib | 19.9526 | uM | 9 | 1250.00 | 830.55 | 912.00 | 1962.75 | 0.4647 | 0.0783 |
| SK-BR-3 | Lapatinib | 0.031623 | uM | 9 | 1250.00 | 830.55 | 1214.00 | 1962.75 | 0.6185 | 0.3579 |
| SK-BR-3 | Lapatinib | 0.0016596 | uM | 9 | 1250.00 | 830.55 | 1944.00 | 1962.75 | 0.9905 | 0.9846 |
| SK-BR-3 | 17-AAG | 0.031623 | uM | 9 | 1250.00 | 830.55 | 794.00 | 1962.75 | 0.4045 | -0.0356 |
| SK-BR-3 | 0 | uM | 9 | 1250.00 | 830.55 | 2020.00 | 1962.75 | 1.0292 | 1.0469 | |
| SK-BR-3 | 0 | uM | 9 | 2500.00 | 1861.36 | 4048.00 | 4181.50 | 0.9681 | 0.9452 | |
| SK-BR-3 | Erlotinib | 0.01 | uM | 9 | 2500.00 | 1861.36 | 4325.00 | 4181.50 | 1.0343 | 1.0586 |
| SK-BR-3 | 17-AAG | 0.000302 | uM | 9 | 2500.00 | 1861.36 | 4615.00 | 4181.50 | 1.1037 | 1.1763 |
| SK-BR-3 | Erlotinib | 0.31623 | uM | 9 | 2500.00 | 1861.36 | 4241.00 | 4181.50 | 1.0142 | 1.0243 |
| SK-BR-3 | Erlotinib | 1 | uM | 9 | 2500.00 | 1861.36 | 4174.00 | 4181.50 | 0.9982 | 0.9969 |
| SK-BR-3 | Lapatinib | 10 | uM | 9 | 2500.00 | 1861.36 | 1513.00 | 4181.50 | 0.3618 | -0.1626 |
| SK-BR-3 | Linsitinib | 0.031623 | uM | 9 | 2500.00 | 1861.36 | 4558.00 | 4181.50 | 1.0900 | 1.1533 |
| SK-BR-3 | 17-AAG | 0.0001 | uM | 9 | 2500.00 | 1861.36 | 4513.00 | 4181.50 | 1.0793 | 1.1350 |
| SK-BR-3 | Erlotinib | 0.031623 | uM | 9 | 2500.00 | 1861.36 | 4527.00 | 4181.50 | 1.0826 | 1.1407 |
| SK-BR-3 | Lapatinib | 1 | uM | 9 | 2500.00 | 1861.36 | 1787.00 | 4181.50 | 0.4274 | -0.0343 |
| SK-BR-3 | Linsitinib | 10 | uM | 9 | 2500.00 | 1861.36 | 3328.00 | 4181.50 | 0.7959 | 0.6448 |
| SK-BR-3 | Erlotinib | 3.1623 | uM | 9 | 2500.00 | 1861.36 | 3620.00 | 4181.50 | 0.8657 | 0.7677 |
| SK-BR-3 | Erlotinib | 10 | uM | 9 | 2500.00 | 1861.36 | 1970.00 | 4181.50 | 0.4711 | 0.0498 |